Mucoadhesive chitosan microspheres of carvedilol for nasal administration

References

• Aiedeh K, Gianasi E, Orienti I, Zecchi V. (1997). Chitosan microcapsules as controlled release systems for insulin. J Microencapsul, 14, 567–576.
   PubMed Web of Science ®Google Scholar
• Alpar HO, Somavarapu S, Atuah KN, Bramwell VW. (2005). Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliv Rev, 57, 411–430.
   PubMed Web of Science ®Google Scholar
• Banker GS, Anderson NR. (1991). In: Lachman L, Lieberman HA, Kanig J, eds. The Theory and Practice Of Industrial Pharmacy pp 317. Mumbai, Maharashtra, India: Varghese publishing house.
   Google Scholar
• Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R. (2004). Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm, 57, 19–34.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Hornof M, Zoidl T. (2003). Thiolated polymers–thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm, 260, 229–237.
   PubMed Web of Science ®Google Scholar
• Berthod F, Saintigny G, Chretien F, Hayek D, Collombel C, Damour O. (1994). Optimization of thickness, pore size and mechanical properties of a biomaterial designed for deep burn coverage. Clin Mater, 15, 259–265.
   PubMedGoogle Scholar
• Blanco MD, Gómez C, Olmo R, Muñiz E, Teijón JM. (2000). Chitosan microspheres in PLG films as devices for cytarabine release. Int J Pharm, 202, 29–39.
   PubMed Web of Science ®Google Scholar
• Chien YW, Su KSE, Chang SF. (1989). Anatomy and physiology of the nose. In: Chien YW, Su KSE, Chang SF, eds. Nasal Systemic Drug Delivery 39, pp 1–19. New York: Marcel Dekker.
   Google Scholar
• Cornaz A, Buri P. (1994). Nasal mucosa as an absorption barrier. Eur J Pharm Biopharm, 40, 261–270.
   Web of Science ®Google Scholar
• Denkbas EB, Seyyal M, Piskin E. (1999). 5-fluorouracil loaded chitosan microspheres for chemoembolization. J Microencapsul, 16, 741–749.
   PubMed Web of Science ®Google Scholar
• Fernandez-Urrusuno R, Romani D, Calvo P, Vila-Jato JL, Alonso MJ. (1999). Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. STP Pharma Sciences, 9, 429–436.
   Google Scholar
• Gavini E, Rassu G, Muzzarelli C, Cossu M, Giunchedi P. (2008). Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. Eur J Pharm Biopharm, 68, 245–252.
   PubMed Web of Science ®Google Scholar
• Gavini E, Rassu G, Sanna V, Cossu M, Giunchedi P. (2005). Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. J Pharm Pharmacol, 57, 287–294.
   PubMed Web of Science ®Google Scholar
• He P, Davis SS, Illum L. (1998). In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm, 166, 75–88.
   Web of Science ®Google Scholar
• Illum L. (1998). Bioadhesive formulations for nasal peptide delivery. In: Mathiowitz E, Lehr CM, Chickering D, eds. Bioadhesion in Drug Delivery - Issues in Fundamentals, Novel Approaches and Development pp 507–539. New York: Marcel Dekker.
   Google Scholar
• Illum L. (2002). Nasal drug delivery: new developments and strategies. Drug Discov Today, 7, 1184–1189.
   PubMed Web of Science ®Google Scholar
• Illum L. (2003). Nasal drug delivery-possibilities, problems and solutions. J Control Rel, 87, 187–198.
   PubMed Web of Science ®Google Scholar
• Illum L, Jorgensen H, Bisgaard H, Krogsgaard O, Rossing N. (1987). Bioadhesive microspheres as a potential nasal drug delivery system. Int J Pharm, 39, 189–199.
   Web of Science ®Google Scholar
• Illum L, Fisher AN, Jabbal-Gill I, Davis SS. (2001). Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int J Pharm, 222, 109–119.
   PubMed Web of Science ®Google Scholar
• Mantle M, Allen A. (1978). A colorimetric assay for glycoproteins based on the periodic acid/Schiff stain [proceedings]. Biochem Soc Trans, 6, 607–609.
   PubMedGoogle Scholar
• Mi FL, Wong TB, Shyu SS, Chang SF. 1999. Chitosan microspheres: modification of polymeric chem-physical properties of spray-dried microspheres to control the release of antibiotic drug. J Applied Polym Science, 71, 747–759.
   Web of Science ®Google Scholar
• Mygind N, Dahl R. 1998. Anatomy, physiology and function of the nasal cavity. Adv Drug Deliv Rev, 29, 3–12.
   PubMed Web of Science ®Google Scholar
• Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Staiger C, Holcslaw TL, Amann-Zalan I, DeMets DL. (2002). Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation, 106, 2194–2199.
   PubMed Web of Science ®Google Scholar
• Patil SB, Murthy RSR. (2006). Preparation and in vitro evaluation of mucoadhesive chitosan microspheres of amlodipine besylate for nasal administration. Ind J Pharm Sci, 8, 64–67.
   Google Scholar
• Patil SB, Sawant KK. (2009). Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery. J Microencapsul, 26, 432–443.
   PubMed Web of Science ®Google Scholar
• Pereswetoff-Morath L. (1998). Microspheres as nasal drug delivery systems. Adv Drug Deliv Rev, 29, 185–194.
   PubMed Web of Science ®Google Scholar
• Ranga Rao KV, Buri P. (1989). A novel situ method to test polymer and coated microparticles for bioadhesion. Int J Pharm, 52, 265–270.
   Web of Science ®Google Scholar
• Ritger PL, Peppas NA. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Rel, 5, 37–42.
   Google Scholar
• Roberts GAF, Taylor KE. (1989). The formation of gels by reaction of chitosan with glutaraldehyde. Macromolecular Chemistry, 190, 951–960.
   Web of Science ®Google Scholar
• Soane RJ, Frier M, Perkins AC, Jones NS, Davis SS, Illum L. (1999). Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm, 178, 55–65.
   PubMed Web of Science ®Google Scholar
• Tafaghodi M, Abolghasem Sajadi Tabassi S, Jaafari MR, Zakavi SR, Momen-Nejad M. (2004). Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Int J Pharm, 280, 125–135.
   PubMed Web of Science ®Google Scholar
• Taylor MK, Ginsburg J, Hickey AJ, Gheyas F. (2000). Composite method to quantify powder flow as a screening method in early t or capsule formulation development. AAPS Pharm Sci Tech, 1, Article 18.
   PubMedGoogle Scholar
• Thanoo BC, Sunny MC, Jayakrishnan A. (1992). Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J Pharm Pharmacol, 44, 283–286.
   PubMed Web of Science ®Google Scholar
• Thummel KE, Shen DD. (2001). Design and optimization of dosage regimens: pharmacokinetic data. In: Hardman JG, Limbirel LE, Gilman AG, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics pp 1936–1940. New York: McGraw Hill.
   Google Scholar
• Ikechukwu Ugwoke M, Kaufmann G, Verbeke N, Kinget R. (2000). Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems. Int J Pharm, 202, 125–131.
   PubMedGoogle Scholar
• Ugwoke MI, Verbeke N, Kinget R. (2001). The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol, 53, 3–21.
   PubMed Web of Science ®Google Scholar
• van der Lubben IM, Kersten G, Fretz MM, Beuvery C, Coos Verhoef J, Junginger HE. (2003). Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine, 21, 1400–1408.
   PubMed Web of Science ®Google Scholar
• Vidgren P, Vidgren M, Vainio P, Nuutinen J, Paronen P. (1991). Double-labeling technique in the evaluation of nasal mucoadhesion of disodium cromoglycate microspheres. Int J Pharm, 73, 131–136.
   Web of Science ®Google Scholar
• Wang YM, Sato H, Adachi I, Horikoshi I. (1996). Optimization of the formulation design of chitosan microspheres containing cisplatin. J Pharm Sci, 85, 1204–1210.
   PubMed Web of Science ®Google Scholar
• Wells J, Aulton M. (1988). Preformulation. In: Aulton ME, ed. Pharmaceutics: The Science of Dosage Form Design pp 223–253. Edinburgh: Churchill Livingstone.
   Google Scholar